Multidisciplinary working group for interstitial lung disease in Thailand: Part 2 – a concise review of published visual scoring methods for interstitial lung disease

Tanomkiat W, Nitiwarangkul C, Euathrongchit J, Thiravit P, Tongbai T, Suwatanapongched T. Multidisciplinary working group for interstitial lung disease in Thailand: Part 1- rationale in developing a guide to estimate the global disease and fibrotic extents on high-resolution computed tomography. ASEAN J Radiol [Internet]. 2021 [cited 2021 Apr 1];22(3):47-60. Available from: https://www.asean-journal-radiology.org/index.php/ajr/article/view/158/106

Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med 2018;6:138-53. doi: 10.1016/S2213-2600(17)30433-2.

Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.

Galhotra RD, Singh G, Saggar K, Saggar K, Gupta K. Primary thoracic manifestations in connective tissue diseases on high resolution computed tomography: a prospective study. IJCMSR 2018;3:25-35.

Bellia M, Cannizzaro F, Scichilone N, Riili M, Triolo G, Midiri M, et al. HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities. Radiol Med 2009;114:190-203. doi: 10.1007/s11547-009-0367-9.

Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008;177:1248-54. doi: 10.1164/rccm.200706-877OC.

Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 1997;169:977-83. doi: 10.2214/ajr.169.4.9308447.

Sánchez RP, Fernández-Fabrellas E, Samper GJ, Montañana ML, Vilar LN. Visual HRCT score to determine severity and prognosis of idiopathic pulmonary fibrosis. Int J Respir Pulm Med 2018;5:084. doi:10.23937/2378-3516/1410084

Wangkaew S, Euathrongchit J, Patiwetwitoon S, Prasertwitayakij N, Kasitanon N, Louthrenoo W. The relevance of high-resolution computed tomographic findings and pulmonary arterial hypertension in systemic sclerosis-associated interstitial lung disease. J Med Assoc Thai 2014;97:878-85.

Wangkaew S, Euathrongchit J, Wattanawittawas P, Kasitanon N, Louthrenoo W. Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study. Mod Rheumatol 2016;26:588-93. doi: 10.3109/14397595.2015.1115455.

Warrick JH, Bhalla M, Schabel SI, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991;18:1520-8.

Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, Saggar R, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007;132:773-9. doi: 10.1378/chest.07-0116.

Wells AU, Rubens MB, du Bois RM, Hansell DM. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol 1993;161:1159-65. doi: 10.2214/ajr.161.6.8249719.

Wells AU, Hansell DM, Corrin B, Harrison NK, Goldstraw P, Black CM, et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992;47:738-42. doi: 10.1136/thx.47.9.738.

Pignone A, Matucci-Cerinic M, Lombardi A, Fedi R, Fargnoli R, De Dominicis R, et al. High resolution computed tomography in systemic sclerosis. Real diagnostic utilities in the assessment of pulmonary involvement and comparison with other modalities of lung investigation. Clin Rheumatol 1992;11:465-72. doi: 10.1007/BF02283100.

Davas EM, Peppas C, Maragou M, Alvanou E, Hondros D, Dantis PC. Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma. Clin Rheumatol 1999;18:455-61. doi: 10.1007/s100670050138.

Shahin AA, Sabri YY, Mostafa HA, Sabry EY, Hamid MA, Gamal H, et al. Pulmonary function tests, high-resolution computerized tomography, alpha1-antitrypsin measurement, and early detection of pulmonary involvement in patients with systemic sclerosis. Rheumatol Int 2001;20:95-100. doi: 10.1007/s002960000089.

Giacomelli R, Valentini G, Salsano F, Cipriani P, Sambo P, Conforti ML, et al. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. J Rheumatol 2002;29:731-6.

Shah RM, Jimenez S, Wechsler R. Significance of ground-glass opacity on HRCT in long-term follow-up of patients with systemic sclerosis. J Thorac Imaging 2007;22:120-4. doi: 10.1097/01.rti.0000213572.16904.40.

Gohari Moghadam K, Gharibdoost F, Parastandechehr G, Salehian P. Assessments of pulmonary involvement in patients with systemic sclerosis. Arch Iran Med 2011;14:22-6.

Diot E, Boissinot E, Asquier E, Guilmot JL, Lemarie E, Valat C, et al. Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis. Chest 1998;114:1623-9. doi: 10.1378/chest.114.6.1623.

Orlandi I, Camiciottoli G, Diciotti S, Bartolucci M, Cavigli E, Nacci F, et al. Thin-section and low-dose volumetric computed tomographic densitometry of the lung in systemic sclerosis. J Comput Assist Tomogr 2006;30:823-7. doi: 10.1097/01.rct.0000228159.86096.47.

Afeltra A, Zennaro D, Garzia P, Gigante A, Vadacca M, Ruggiero A, et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol 2006;35:388-94. doi: 10.1080/03009740600844381.

Camiciottoli G, Orlandi I, Bartolucci M, Meoni E, Nacci F, Diciotti S, et al. Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest 2007;131:672-81. doi: 10.1378/chest.06-1401.

Yiannopoulos G, Pastromas V, Antonopoulos I, Katsiberis G, Kalliolias G, Liossis SN, et al. Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease. Rheumatol Int 2007;27:357-61. doi: 10.1007/s00296-006-0217-1.

Savarino E, Bazzica M, Zentilin P, Pohl D, Parodi A, Cittadini G, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 2009;179:408-13. doi: 10.1164/rccm.200808-1359OC.

Daoussis D, Liossis SN, Tsamandas AC, Kalogeropoulou C, Kazantzi A, Sirinian C, et al. Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology (Oxford) 2010;49:271-80. doi: 10.1093/rheumatology/kep093.

Ooi GC, Mok MY, Tsang KW, Wong Y, Khong PL, Fung PC, et al. Interstitial lung disease in systemic sclerosis. Acta Radiol 2003;44:258-64. doi: 10.1034/j.1600-0455.2003.00058.x.

Choi HJ, Shin YK, Lee HJ, Kee JY, Shin DW, Lee EY, et al. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients. Clin Rheumatol 2008;27:437-42. doi: 10.1007/s10067-007-0724-9.

Mok MY, Fung PC, Ooi C, Tse HF, Wong Y, Lam YM, et al. Serum nitric oxide metabolites and disease activity in patients with systemic sclerosis. Clin Rheumatol 2008;27:315-22. doi: 10.1007/s10067-007-0708-9.

Pandey AK, Wilcox P, Mayo JR, Sin D, Moss R, Ellis J, et al. Predictors of pulmonary hypertension on high-resolution computed tomography of the chest in systemic sclerosis: a retrospective analysis. Can Assoc Radiol J 2010;61:291-6. doi: 10.1016/j.carj.2010.02.006.

Tiev KP, Cabane J, Aubourg F, Kettaneh A, Ziani M, Mouthon L, et al. Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide. Eur Respir J 2007;30:26-30. doi: 10.1183/09031936.00129806.

Goldin J, Elashoff R, Kim HJ, Yan X, Lynch D, Strollo D, et al. Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study. Chest 2009;136:1333-40. doi: 10.1378/chest.09-0108.

Wells AU, Hansell DM, Rubens MB, King AD, Cramer D, Black CM, et al. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography. Arthritis Rheum 1997;40:1229-36. doi: 10.1002/1529-0131(199707)40:7<1229::AID-ART6>3.0.CO;2-W.

Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004;232:560-7. doi: 10.1148/radiol.2322031223.

Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006;54:3962-70. doi: 10.1002/art.22204.

Assayag D, Kaduri S, Hudson M, Hirsch A, Baron M. High resolution computed tomography scoring systems for evaluating interstitial lung disease in systemic sclerosis patients. Rheumatology 2012;S1:003. Doi: 10.4172/2161-1149.S1-003

Suwatanapongched T, Nitiwarangkul C, Euathrongchit J, Thiravit P, Tongbai T,Tanomkiat W. Multidisciplinary working group for interstitial lung disease in Thailand: Part 3- proposed visual scoring method for quantifying the global disease and fibrotic extents on high-resolution CT. ASEAN J Radiol In press 2022.